Ocular therapeutic agent delivery devices and methods for making and using such devices

US6713081B2 · kind B2 · utility

Assignee

• The United States of America, as represented by the Department of Health and Human Services · US

Inventors

• Michael R. Robinson · Irvine, US
• Karl Csaky · Dallas, US
• Peng Yuan · Houston, US
• Cynthia Sung · Silver Spring, US
• Robert Nussenblatt · Bethesda, US
• Janine A. Smith · Potomac, US

Key dates

• Filing date: Mar 15, 2001
• Grant date: Mar 30, 2004
• Expiry date: Mar 15, 2021

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S425/808
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Ocular implant devices for the delivery of a therapeutic agent to an eye in a controlled and sustained manner. Dual mode and single mode drug delivery devices are illustrated and described. Implants suitable for subconjunctival placement are described. Implants suitable for intravitreal placement also are described. The invention also includes fabrication and implementation techniques associated with the unique ocular implant devices that are presented herein.